Increasing evidence indicates that RBM39 influences the growth of a range of malignancies, including cholangiocarcinoma, rectum adenocarcinoma, kidney clear cell carcinoma, kidney papillary cell carcinoma, lung SCC, and HNSCCs [127]. This evidence concerns the gene RBM39 and cholangiocarcinoma.